Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Savara Inc (NASDAQ:SVRA)

15.32
Delayed Data
As of 4:00pm ET
 +0.79 / +5.44%
Today’s Change
4.60
Today|||52-Week Range
16.23
+152.14%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$443.2M

Company Description

Savara, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its products include AeroVanc, Molgradex, GM-CSF, and Aironite. The company was founded on April 27, 2017 and is headquartered in Austin, TX.

Contact Information

Savara, Inc.
900 South Capital of Texas Highway
Austin Texas 78746
P:(512) 961-1891
Investor Relations:

Employees

Shareholders

Mutual fund holders2.11%
Other institutional12.99%
Individual stakeholders10.66%

Top Executives

Robert Norman NevilleChairman & Chief Executive Officer
Taneli JouhikainenPresident & Chief Operating Officer
David L. LowranceChief Financial Officer
Cecilia GanslandtVice President-Medical Affairs
Michael CieslaVP-Finance & Director-SEC Reporting